The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity

[1]  C. Spielberger,et al.  STAI manual for the State-trait anxiety inventory ("self-evaluation questionnaire") , 1970 .

[2]  Leslie G. Ungerleider,et al.  Mechanisms of directed attention in the human extrastriate cortex as revealed by functional MRI. , 1998, Science.

[3]  Qing Lu,et al.  Impaired prefrontal–amygdala effective connectivity is responsible for the dysfunction of emotion process in major depressive disorder: A dynamic causal modeling study on MEG , 2012, Neuroscience Letters.

[4]  Patrik Vuilleumier,et al.  Affective and motivational control of vision. , 2015, Current opinion in neurology.

[5]  Karl J. Friston,et al.  Comparing dynamic causal models , 2004, NeuroImage.

[6]  Robert T. Schultz,et al.  Bidirectional communication between amygdala and fusiform gyrus during facial recognition , 2011, NeuroImage.

[7]  Siegfried Kasper,et al.  Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder , 2011, NeuroImage.

[8]  F. Vollenweider,et al.  Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors , 2012, Biological Psychiatry.

[9]  M. Egan,et al.  Serotonin Transporter Genetic Variation and the Response of the Human Amygdala , 2002, Science.

[10]  A. Kemp,et al.  Acute neural effects of selective serotonin reuptake inhibitors versus noradrenaline reuptake inhibitors on emotion processing: Implications for differential treatment efficacy , 2013, Neuroscience & Biobehavioral Reviews.

[11]  大坪天平.  Mini-International Nearopsychiatric Interview (M. I. N. I.)日本語版の作成と信頼性・妥当性の検討 , 2000 .

[12]  Felix Hasler,et al.  Acute psychological and physiological effects of psilocybin in healthy humans : a double-blind , placebo-controlled dose – effect study , 2004 .

[13]  D. Amaral,et al.  Synaptic organization of projections from the amygdala to visual cortical areas TE and V1 in the macaque monkey , 2005, The Journal of comparative neurology.

[14]  H Fischer,et al.  Altered fusiform connectivity during processing of fearful faces in social anxiety disorder , 2013, Translational Psychiatry.

[15]  Karl J. Friston,et al.  Bayesian model selection for group studies , 2009, NeuroImage.

[16]  Karl J. Friston,et al.  A neuromodulatory role for the human amygdala in processing emotional facial expressions. , 1998, Brain : a journal of neurology.

[17]  Karl J. Friston,et al.  Comparing hemodynamic models with DCM , 2007, NeuroImage.

[18]  F. Vollenweider,et al.  The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions , 2012, Psychopharmacology.

[19]  Karl J. Friston,et al.  Dynamic causal modelling , 2003, NeuroImage.

[20]  Christian Windischberger,et al.  (S)-citalopram influences amygdala modulation in healthy subjects: a randomized placebo-controlled double-blind fMRI study using dynamic causal modeling , 2015, NeuroImage.

[21]  Julie C Price,et al.  Medial prefrontal cortex 5-HT(2A) density is correlated with amygdala reactivity, response habituation, and functional coupling. , 2009, Cerebral cortex.

[22]  Karl J. Friston,et al.  Unified segmentation , 2005, NeuroImage.

[23]  D. Amaral,et al.  The organization of projections from the amygdala to visual cortical areas TE and V1 in the macaque monkey , 2005, The Journal of comparative neurology.

[24]  P. Lang.  International affective picture system (IAPS) : affective ratings of pictures and instruction manual , 2005 .

[25]  G. Fink,et al.  Noradrenergic modulation of cortical networks engaged in visuomotor processing. , 2010, Cerebral cortex.

[26]  F. Vollenweider,et al.  Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers , 2015, Biological Psychiatry.

[27]  Christian Grillon,et al.  The role of serotonin in the neurocircuitry of negative affective bias: Serotonergic modulation of the dorsal medial prefrontal-amygdala ‘aversive amplification’ circuit , 2013, NeuroImage.

[28]  James B. Rowe,et al.  Reversed Frontotemporal Connectivity During Emotional Face Processing in Remitted Depression , 2012, Biological Psychiatry.

[29]  D. Rosielle,et al.  Psychiatry , 1905, NeuroImage.

[30]  Karl J. Friston,et al.  Behavioral/systems/cognitive Effective Connectivity during Processing of Facial Affect: Evidence for Multiple Parallel Pathways , 2022 .

[31]  M. First,et al.  Structured clinical interview for DSM-IV axis II personality disorders : SCID-II , 1997 .

[32]  D. Rainnie.  Serotonergic modulation of neurotransmission in the rat basolateral amygdala. , 1999, Journal of neurophysiology.

[33]  S. Aznar,et al.  Regulating Prefrontal Cortex Activation: An Emerging Role for the 5-HT2A Serotonin Receptor in the Modulation of Emotion-Based Actions? , 2013, Molecular Neurobiology.

[34]  B. Franke,et al.  Reduced Serotonin Transporter Availability Decreases Prefrontal Control of the Amygdala , 2013, The Journal of Neuroscience.

[35]  R. E. Schultes.  Halluzinogene — psychische grenzzustande in forschung und psychotherapie: Hanscarl Leuner, Verlag Hans Huber, Bern, 1981, 458 pp., 33 figs., tables 5 (DM48.00, approx. US$22.00) , 1984 .

[36]  H. Leuner.  Halluzinogene : psychische Grenzzustände in Forschung u. Psychotherapie , 1981 .

[37]  D. Roger,et al.  Self-Evaluation Questionnaire , 2014 .

[38]  Michael Kometer,et al.  The neurobiology of psychedelic drugs: implications for the treatment of mood disorders , 2010, Nature Reviews Neuroscience.

[39]  Karl J. Friston,et al.  Statistical parametric maps in functional imaging: A general linear approach , 1994 .

[40]  Paul Allen,et al.  Brain connectivity abnormalities predating the onset of psychosis: correlation with the effect of medication. , 2013, JAMA psychiatry.

[41]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[42]  C. Beevers,et al.  Neural mechanisms of the cognitive model of depression , 2011, Nature Reviews Neuroscience.

[43]  L. Pessoa,et al.  Emotion processing and the amygdala: from a 'low road' to 'many roads' of evaluating biological significance , 2010, Nature Reviews Neuroscience.

[44]  Karl J. Friston,et al.  Top-Down Control of Visual Responses to Fear by the Amygdala , 2013, The Journal of Neuroscience.

[45]  C. Spielberger,et al.  Manual for the state-trait anxiety inventory (form Y) : "self-evaluation questionnaire" , 1983 .

[46]  D. Watson,et al.  Development and validation of brief measures of positive and negative affect: the PANAS scales. , 1988, Journal of personality and social psychology.

[47]  Felix Hasler,et al.  Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies , 2011, Journal of psychopharmacology.